MR-Guideline? [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2010-04-23 14:34 (5910 d 18:08 ago) – Posting: # 5197
Views: 26,736

Dear Marcel!

You did not dig deep enough. At the end of the table on page 60 it is stated:
CPMP/EWP/280/96 – Note for guidance on Modified Release Oral and Transdermal Dosage Forms: Section II – Revision to be considered

❝ If this is still the case, in your opinion can we expect a draft guidance out in 2010?


Don’t know. I’m not optimistic for a draft that early. As an example: regulators talked at conferences about a revision of the (IR)BE-GL in mid-2004, the Q&A was published as some kind of ‘intermediate’ in 2006, the ‘Recommendation on the Need for Revision of NfG on BA/BE’ in 2007, and the draft in 2008…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
413 visitors (0 registered, 413 guests [including 19 identified bots]).
Forum time: 08:42 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5